نتایج جستجو برای: thrombophilic markers

تعداد نتایج: 223187  

Journal: :Clinical science 2003
Masatoshi Hayashi

Schlembach and co-workers in this issue of Clinical Science have studied the association of maternal and/or fetal factor V Leiden (FVL) and prothrombin G20210A gene mutation with HELLP syndrome and intrauterine growth restriction (IUGR) to confirm whether these genetic mutations are important risk factors for the pathogenesis of the HELLP syndrome, leading to an inadequate maternal-fetal circul...

Journal: :BMJ 2014
Peter MacCallum Louise Bowles David Keeling

The term thrombophilia refers to an abnormality of blood coagulation that increases the risk of thrombosis. Such abnormalities represent one component of the triad (along with stasis and abnormalities of the vessel wall) put forward by Virchow in the 19th century to explain why thrombosis occurs. Thrombophilic abnormalities may be heritable (the topic of this review) or acquired, although both ...

Journal: :Journal of Clinical and Experimental Investigations 2010

Journal: :Developmental Medicine & Child Neurology 2011

Journal: :Arquivos Brasileiros de Oftalmologia 2007

2016
Seh Hyun Kim

Neonatal cerebral sinovenous thrombosis (CSVT) is a rare disease with severe neu­ rological sequelae. Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme in the folate cycle, and mutations in MTHFR are associated with vascular diseases. Here, we report the case of a newborn with MTHFR mutation­associated CSVT. Analysis of MTHFR in the patient detected heterozygous C677T (677CT) and A129...

Journal: :BMJ 2001
B Cosmi C Legnani F Bernardi S Coccheri G Palareti

Common inherited thrombophilic defects such as factor V Leiden and G20120A mutation of the prothrombin gene interact synergistically with oral contraceptives to increase the risk of venous thromboembolism. 2 The best approach to identify women at higher risk of venous thromboembolism before taking oral contraceptives is controversial. Universal screening is not cost effective because 8000 women...

Journal: :Folia histochemica et cytobiologica 2011
Bożena Sokołowska Aleksandra Nowaczyńska Ksenia Bykowska Sylwia Chocholska Katarzyna Wejksza Adam Walter-Croneck Tomasz Gromek Anna M Kowalska Martyna Kandefer-Szerszeń Anna Dmoszyńska

The recently discovered JAK2 V617F point mutation, found in 50-60% of ET patients, has been reported to be associated with a higher risk of thrombotic events. In this study, we explored if JAK2 V617F mutation, or coexisting thrombophilic and hemostatic risk factors, contributed to these complications. We examined 32 patients with ET, and looked for pathogenetic JAK2 V617F mutation and prothromb...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید